July 30th, 2019
MBio Diagnostics featured in the Denver Business Journal, "How a Colorado biotech company aims to do what Theranos couldn't"
August 4th-8th, 2019
MBio Diagnostics will be exhibiting at AACC in Anaheim, CA. Booth 2380.
August 15th, 2019
MBio Diagnostics will be hosting the CPIA Quarterly Meeting at the MBio facility in Boulder, CO, register to attend here.
August 20th, 2019
Chris Myatt will be leading a panel discussion on, "Current Trends in the Veterinary Dx Space" at the Next Generation Dx Summit in Washington, DC
August 21st, 2019
Chris Myatt will be leading a short course on, "Microfluidics and Lab-on-a-Chip Devices for POCT: Technologies and Commercialization" at the Next Generation Dx Summit in Washington, DC
MBio Diagnostics, Inc. Announces Two Contracts for Sepsis Test Development
Brava Diagnostics Announces Exclusive License Agreement and Collaboration with MBio Diagnostics for Point-of-Care Tests
MBio Announces License and Development Partnership with Heska
DARPA Awards MBio Phase II Contract for Acute Infection Point-of-Care-System
MBio Diagnostics Expands IP Portfolio - Announces Issuance of Two New Patents
January 4, 2018